During the recent session, Takeda Pharmaceutical Co ADR (NYSE:TAK)’s traded shares were 0.98 million, with the beta value of the company hitting 0.26. At the last check today, the stock’s price was $14.51, reflecting an intraday gain of 1.65% or $0.24. The 52-week high for the TAK share is $15.43, that puts it down -6.34 from that peak though still a striking 13.37% gain since the share price plummeted to a 52-week low of $12.57. The company’s market capitalization is $45.99B, and the average trade volume was 1.91 million shares over the past three months.
Takeda Pharmaceutical Co ADR (TAK) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.00. TAK has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it.
Takeda Pharmaceutical Co ADR (NYSE:TAK) trade information
Takeda Pharmaceutical Co ADR (TAK) registered a 1.65% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 1.65% in intraday trading to $14.51, hitting a weekly high. The stock’s 5-day price performance is -5.32%, and it has moved by 1.15% in 30 days. Based on these gigs, the overall price performance for the year is 9.22%.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 11.40%. While earnings are projected to return 108.35% in 2025, the next five years will return 42.17% per annum.
TAK Dividends
Takeda Pharmaceutical Co ADR is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance. Investors should also take the other fundamental and operational aspects into account before investing in the stock. The forward dividend ratio for Takeda Pharmaceutical Co ADR is 0.33, with the dividend yield indicating at 2.25 percent, continuing the trend of increasing dividends in recent years.
The next largest institutional holding, with 7.74 million shares, is of MONDRIAN INVESTMENT PARTNERS LTD’s that is approximately 0.4933% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $108.34 million.
Also, the Mutual Funds coming in first place with the largest holdings of Takeda Pharmaceutical Co ADR (TAK) shares are AMERICAN MUTUAL FUND and First TRT Exch-Trd Fd.-First TRT Value Line Dividend Index Fd. . Data provided on Mar 31, 2025 indicates that AMERICAN MUTUAL FUND owns about 12.89 shares. This amounts to just over 0.41 percent of the company’s overall shares, with a $187.26 million market value. The same data shows that the other fund manager holds slightly less at 2.72, or about 0.09% of the stock, which is worth about $39.51 million.
